"A phase II, randomized, double-blind, parallel-group, placebo-controlled, oral food challenge trial of XOLAIR® (omalizumab) in peanut allergy (TOPS)" (vol 119, pg S117, 2007)

被引：0
|
作者：
Sampson, H. A. [1 ]
Leung, D. Y. M.
Burks, A. W.
Lack, G.
Bahna, L.
Jones, S. M.
Varchavsky, J.
Wong, D. A.
Deniz, Y.
机构：
[1] Mt Sinai Sch Med, New York, NY 10029 USA
[2] Natl Jewish Med & Res Ctr, Denver, CO USA
[3] Duke Univ, Med Ctr, Durham, NC USA
[4] St Marys Hosp, London, England
[5] Louisiana State Univ, Hlth Sci Ctr, Shreveport, LA 71105 USA
[6] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
[7] Genentech Inc, San Francisco, CA 94080 USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2007年 / 119卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1025 / 1025
页数：1
相关论文
共 50 条
  • [21] Intrauterine Instillation of Tranexamic Acid in Hysteroscopic Myomectomy: A Double-Blind, Placebo-Controlled, Parallel-Group Randomized Clinical Trial
    Rasheedy, Radwa
    Makled, Ahmed
    Abou-Gamrah, Amgad
    Giuma, Hajer
    JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2020, 27 (06) : 1264 - +
  • [22] Omega-3 supplementation in young offenders: a randomized, stratified, double-blind, placebo-controlled, parallel-group trial
    Adrian Raine
    Chi-Ching Leung
    Melvinder Singh
    Jasmin Kaur
    Journal of Experimental Criminology, 2020, 16 : 389 - 405
  • [23] Estimating the Probability of Tolerating Each Challenge Dose of Peanut Protein at Exit Double-Blind, Placebo-Controlled Food Challenge: Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE) of AR101
    Carr, Warner
    Vickery, Brian P.
    Zawadzki, Rezi
    Griffin, Noelle M.
    Adelman, Daniel C.
    Kim, Edwin
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB262 - AB262
  • [24] Phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study of ustekinumab in patients with Takayasu arteritis
    Yoshifuji, Hajime
    Ishii, Tomonori
    Ohashi, Hiroki
    Yoshizawa, Katsunori
    Mihoya, Maki
    Nishikawa, Kazuko
    Nakaoka, Yoshikazu
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2025, 9 (02)
  • [25] A Randomized, Double-Blind, Placebo-Controlled Trial of Omalizumab Combined with Oral Immunotherapy (OIT) in the Treatment of Cow's Milk Allergy (CMA): Safety of Dosing
    Kim, Jennifer S.
    Wood, Robert A.
    Lindblad, Robert
    Noone, Sally A.
    Paterakis, Melissa N.
    Henning, Alice
    Nadeau, Kari C.
    Spann, Kyrsten
    Sampson, Hugh A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB403 - AB403
  • [26] Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: A randomized, prospective, parallel-group, double-blind, placebo-controlled study
    Loder, E
    Silberstein, SD
    Abu-Shakra, S
    Mueller, L
    Smith, T
    HEADACHE, 2004, 44 (02): : 120 - 130
  • [27] A randomized, double-blind, parallel-group, placebo-controlled, multicenter, phase II clinical study of famitinib in the treatment of advanced metastatic colorectal cancer
    Xu, Rui-Hua
    Shen, Lin
    Wang, Keming
    Wu, Gang
    Shi, Chunmei
    Ding, Kefeng
    Lin, Lizhu
    Wang, Jinwan
    Xiong, Jianping
    Wu, Changping
    Li, Jin
    Liu, Yunpeng
    Wang, Dong
    Ba, Yi
    Feng, Jueping
    Bai, Yuxian
    Bi, JingWang
    Ma, Liwen
    Lei, Jian
    Yu, Hao
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [28] The Effect of Cysteine Peptide Ingestion on Skin Brightness, a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Human Clinical Trial
    Uchida, Yoshiaki
    Kaneda, Tomomi
    Ono, Mio
    Matsuoka, Masao
    Nakamura, Utano
    Ishida, Akiko
    Yamasaki, Yoshimitsu
    Takeo, Hiroki
    Sakurai, Takanobu
    COSMETICS, 2023, 10 (03)
  • [29] Efficacy of andrographolide in not active progressive multiple sclerosis: a prospective exploratory double-blind, parallel-group, randomized, placebo-controlled trial
    Ethel Ciampi
    Reinaldo Uribe-San-Martin
    Claudia Cárcamo
    Juan Pablo Cruz
    Ana Reyes
    Diego Reyes
    Carmen Pinto
    Macarena Vásquez
    Rafael A. Burgos
    Juan Hancke
    BMC Neurology, 20
  • [30] Stimulation of the Prefrontal Cortex Reduces Intentions to Commit Aggression: A Randomized, Double-Blind, Placebo-Controlled, Stratified, Parallel-Group Trial
    Choy, Olivia
    Raine, Adrian
    Hamilton, Roy H.
    JOURNAL OF NEUROSCIENCE, 2018, 38 (29): : 6505 - 6512
12345